James Cavanaugh - Sep 1, 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi as attorney-in-fact for James Cavanaugh
Stock symbol
LPTX
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 09:41 PM
Previous filing
Feb 3, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Stock Option (Right to Buy) Award $0 +25K $0.00 25K Sep 1, 2022 Common Stock 25K $1.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.